Contribution of extracellular matrix to the mechanical properties of the heart

Journal of Molecular and Cellular Cardiology

Volumn 48, Issue 3, 2010, Pages 490-496

  Fomovsky, Gregory M ^a   Thomopoulos, Stavros ^b   Holmes, Jeffrey W ^c  

^a Columbia University ^*  (United States)

^b WASHINGTON UNIVERSITY   (United States)

^c UNIVERSITY OF VIRGINIA   (United States)

Author keywords

Collagen; Constitutive model; Elastin; Proteoglycans; Residual stress

Indexed keywords

ADVANCED GLYCATION END PRODUCT; ELASTIN; FIBRILLAR COLLAGEN; MATRIX METALLOPROTEINASE; PROTEOGLYCAN;

ARTICULAR CARTILAGE; CROSS LINKING; DIASTOLIC DYSFUNCTION; EXTRACELLULAR MATRIX; HEART FAILURE; HEART INFARCTION; HEART LEFT VENTRICLE OVERLOAD; HEART MUSCLE; HEART MUSCLE FIBROSIS; HEART VENTRICLE HYPERTROPHY; HEART VENTRICLE REMODELING; HUMAN; MATHEMATICAL MODEL; MECHANOTRANSDUCTION; MOLECULAR DYNAMICS; NONHUMAN; PERICARDIUM; PREDICTION; PRIORITY JOURNAL; REVIEW; STRESS STRAIN RELATIONSHIP;

ANIMALS; BIOMECHANICS; COLLAGEN; ELASTIN; EXTRACELLULAR MATRIX; HEART; HUMANS; MODELS, BIOLOGICAL; MYOCARDIUM; PROTEOGLYCANS;

EID: 77649275856     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2009.08.003     Document Type: Review

References (63)

1. Sacks M.S. Incorporation of experimentally-derived fiber orientation into a structural constitutive model for planar collagenous tissues. J. Biomech. Eng. 2003, 125(2):280-287.
2. Liao J., Yang L., Grashow J., Sacks M.S. Molecular orientation of collagen in intact planar connective tissues under biaxial stretch. Acta. Biomater. 2005, 1(1):45-54.
3. Weber K.T. Cardiac interstitium in health and disease: the fibrillar collagen network. J Am Coll. Cardiol. 1989, 13(7):1637-1652.
4. Bing O.H., Matsushita S., Fanburg B.L., Levine H.J. Mechanical properties of rat cardiac muscle during experimental hypertrophy. Circ. Res. 1971, 28(2):234-245.
5. Villari B., Campbell S.E., Hess O.M., Mall G., Vassalli G., Weber K.T., et al. Influence of collagen network on left ventricular systolic and diastolic function in aortic valve disease. J. Am. Coll. Cardiol. 1993, 22(5):1477-1484.
6. Weber K.T., Brilla C.G., Janicki J.S. Myocardial fibrosis: functional significance and regulatory factors. Cardiovasc. Res 1993, 27(3):341-348.
7. Borg T.K., Ranson W.F., Moslehy F.A., Caulfield J.B. Structural basis of ventricular stiffness. Lab. Invest. 1981, 44(1):49-54.
8. Bing O.H., Fanburg B.L., Brooks W.W., Matsushita S. The effect of the lathyrogen beta-amino proprionitrile (BAPN) on the mechanical properties of experimentally hypertrophied rat cardiac muscle. Circ. Res. 1978, 43(4):632-637.
9. Kato S., Spinale F.G., Tanaka R., Johnson W., Cooper G.T., Zile M.R. Inhibition of collagen cross-linking: effects on fibrillar collagen and ventricular diastolic function. Am. J. Physiol. 1995, 269(3 Pt 2):H863-H868.
10. MacKenna D.A., Omens J.H., McCulloch A.D., Covell J.W. Contribution of collagen matrix to passive left ventricular mechanics in isolated rat hearts. Am. J. Physiol. 1994, 266(3 Pt 2):H1007-H1018.
11. Todaka K., Jiang T., Chapman J.T., Gu A., Zhu S.M., Herzog E., et al. Functional consequences of acute collagen degradation studied in crystalloid perfused rat hearts. Basic. Res. Cardiol. 1997 Jun, 92(3):147-158.
12. Stroud J.D., Baicu C.F., Barnes M.A., Spinale F.G., Zile M.R. Viscoelastic properties of pressure overload hypertrophied myocardium: effect of serine protease treatment. Am. J. Physiol. Heart. Circ. Physiol. 2002, 282(6):H2324-H2335.
13. Granzier H.L., Irving T.C. Passive tension in cardiac muscle: contribution of collagen, titin, microtubules, and intermediate filaments. Biophys. J. 1995, 68(3):1027-1044.
14. Badenhorst D., Maseko M., Tsotetsi O.J., Naidoo A., Brooksbank R., Norton G.R., et al. Cross-linking influences the impact of quantitative changes in myocardial collagen on cardiac stiffness and remodelling in hypertension in rats. Cardiovasc. Res. 2003, 57(3):632-641.
15. Lopez B., Querejeta R., Gonzalez A., Beaumont J., Larman M., Diez J. Impact of treatment on myocardial lysyl oxidase expression and collagen cross-linking in patients with heart failure. Hypertension 2009, 53(2):236-242.
16. Aronson D. Cross-linking of glycated collagen in the pathogenesis of arterial and myocardial stiffening of aging and diabetes. J. Hypertens. 2003, 21(1):3-12.
17. Holmes J.W., Borg T.K., Covell J.W. Structure and mechanics of healing myocardial infarcts. Annu. Rev. Biomed. Eng. 2005, 7:223-253.
18. Chapman D., Weber K.T., Eghbali M. Regulation of fibrillar collagen types I and III and basement membrane type IV collagen gene expression in pressure overloaded rat myocardium. Circ. Res. 1990, 67(4):787-794.
19. Pauschinger M., Knopf D., Petschauer S., Doerner A., Poller W., Schwimmbeck P.L., et al. Dilated cardiomyopathy is associated with significant changes in collagen type I/III ratio. Circulation 1999, 99(21):2750-2756.
20. Cleutjens J.P., Verluyten M.J., Smiths J.F., Daemen M.J. Collagen remodeling after myocardial infarction in the rat heart. Am. J. Pathol. 1995, 147(2):325-338.
21. Pope A.J., Sands G.B., Smaill B.H., LeGrice I.J. Three-dimensional transmural organization of perimysial collagen in the heart. Am. J. Physiol. Heart. Circ. Physiol. 2008, 295(3):H1243-H1252.
22. Dokos S., Smaill B.H., Young A.A., LeGrice I.J. Shear properties of passive ventricular myocardium. Am. J. Physiol. Heart. Circ. Physiol. 2002, 283(6):H2650-H2659.
23. Schmid H., O'Callaghan P., Nash M.P., Lin W., LeGrice I.J., Smaill B.H., et al. Myocardial material parameter estimation: a non-homogeneous finite element study from simple shear tests. Biomech. Model. Mechanobiol. 2008, 7(3):161-173.
24. Costa K.D., Holmes J.W., McCulloch A.D. Modeling cardiac mechanical properties in three dimensions. Phil. Trans. R. Soc. Lond. A. 2001, 359:1233-1250.
25. MacKenna D.A., Vaplon S.M., McCulloch A.D. Microstructural model of perimysial collagen fibers for resting myocardial mechanics during ventricular filling. Am. J. Physiol. 1997 Sep, 273(3 Pt 2):H1576-H1586.
26. Thomopoulos S., Fomovsky G.M., Holmes J.W. The development of structural and mechanical anisotropy in fibroblast populated collagen gels. J. Biomech. Eng. 2005, 127(5):742-750.
27. Thomopoulos S., Fomovsky G.M., Chandran P.L., Holmes J.W. Collagen fiber alignment does not explain mechanical anisotropy in fibroblast populated collagen gels. J. Biomech. Eng. 2007, 129(5):642-650.
28. Elbjeirami W.M., Yonter E.O., Starcher B.C., West J.L. Enhancing mechanical properties of tissue-engineered constructs via lysyl oxidase crosslinking activity. J. Biomed. Mater. Res. A. 2003, 66(3):513-521.
29. Girton T.S., Oegema T.R., Tranquillo R.T. Exploiting glycation to stiffen and strengthen tissue equivalents for tissue engineering. J. Biomed. Mater. Res. 1999, 46(1):87-92.
30. Shadwick R.E. Mechanical design in arteries. J. Exp. Biol. 1999, 202(Pt 23):3305-3313.
31. Milnor W.R. Hemodynamics 1982, Williams & Wilkins, Baltimore.
32. Bergel D.H. The dynamic elastic properties of the arterial wall. J. Physiol. 1961, 156(3):458-469.
33. Izzo J.L., Mitchell G.F. Aging and arterial structure-function relations. Adv. Cardiol. 2007, 44:19-34.
34. Roach M.R., Burton A.C. The reason for the shape of the distensibility curves of arteries. Can. J. Biochem. Physiol. 1957, 35(8):681-690.
35. Gleason R.L., Humphrey J.D. A 2D constrained mixture model for arterial adaptations to large changes in flow, pressure and axial stretch. Math. Med. Biol. 2005, 22(4):347-369.
36. Sato S., Ashraf M., Millard R.W., Fujiwara H., Schwartz A. Connective tissue changes in early ischemia of porcine myocardium: an ultrastructural study. J. Mol. Cell. Cardiol. 1983, 15(4):261-275.
37. Henderson B.C., Sen U., Reynolds C., Moshal K.S., Ovechkin A., Tyagi N., et al. Reversal of systemic hypertension-associated cardiac remodeling in chronic pressure overload myocardium by ciglitazone. Int. J. Biol. Sci. 2007, 3(6):385-392.
38. Cheng X.W., Obata K., Kuzuya M., Izawa H., Nakamura K., Asai E., et al. Elastolytic cathepsin induction/activation system exists in myocardium and is upregulated in hypertensive heart failure. Hypertension 2006, 48(5):979-987.
39. Mujumdar V.S., Tyagi S.C. Temporal regulation of extracellular matrix components in transition from compensatory hypertrophy to decompensatory heart failure. J. Hypertens. 1999, 17(2):261-270.
40. Jobsis P.D., Ashikaga H., Wen H., Rothstein E.C., Horvath K.A., McVeigh E.R., et al. The visceral pericardium: macromolecular structure and contribution to passive mechanical properties of the left ventricle. Am. J. Physiol. Heart. Circ. Physiol. 2007, 293(6):H3379-H3387.
41. Wagenseil J.E., Ciliberto C.H., Knutsen R.H., Levy M.A., Kovacs A., Mecham R.P. Reduced vessel elasticity alters cardiovascular structure and function in newborn mice. Circ. Res. 2009, 104(10):1217-1224.
42. Faury G., Pezet M., Knutsen R.H., Boyle W.A., Heximer S.P., McLean S.E., et al. Developmental adaptation of the mouse cardiovascular system to elastin haploinsufficiency. J. Clin. Invest. 2003, 112(9):1419-1428.
43. Mizuno T., Yau T.M., Weisel R.D., Kiani C.G., Li R.K. Elastin stabilizes an infarct and preserves ventricular function. Circulation 2005, 112(9 Suppl):I81-I88.
44. Mow V.C., Ratcliffe A. Structure and function of articular cartilage and meniscus. Basic Orthopaedic Biomechanics 1997, 113-177. Lippincott-Raven, Philadelphia. V.C. Mow, W.C. Hayes (Eds.).
45. Akizuki S., Mow V.C., Muller F., Pita J.C., Howell D.S., Manicourt D.H. Tensile properties of human knee joint cartilage: I. Influence of ionic conditions, weight bearing, and fibrillation on the tensile modulus. J. Orthop. Res. 1986, 4(4):379-392.
46. Armstrong C.G., Mow V.C. Variations in the intrinsic mechanical properties of human articular cartilage with age, degeneration, and water content. J. Bone. Joint. Surg. Am. 1982, 64(1):88-94.
47. Kempson G.E., Muir H., Swanson S.A., Freeman M.A. Correlations between stiffness and the chemical constituents of cartilage on the human femoral head. Biochim. Biophys. Acta. 1970, 215(1):70-77.
48. Setton L.A., Elliott D.M., Mow V.C. Altered mechanics of cartilage with osteoarthritis: human osteoarthritis and an experimental model of joint degeneration. Osteoarthritis. Cartilage. 1999, 7(1):2-14.
49. Harris E.D., Parker H.G., Radin E.L., Krane S.M. Effects of proteolytic enzymes on structural and mechanical properties of cartilage. Arthritis. Rheum. 1972, 15(5):497-503.
50. Zhu W., Mow V.C., Koob T.J., Eyre D.R. Viscoelastic shear properties of articular cartilage and the effects of glycosidase treatments. J. Orthop. Res. 1993, 11(6):771-781.
51. Azeloglu E.U., Albro M.B., Thimmappa V.A., Ateshian G.A., Costa K.D. Heterogeneous transmural proteoglycan distribution provides a mechanism for regulating residual stresses in the aorta. Am. J. Physiol. Heart. Circ. Physiol. 2008, 294(3):H1197-H1205.
52. Bereczki E., Santha M. The role of biglycan in the heart. Connect. Tissue. Res. 2008, 49(3):129-132.
53. May-Newman K., McCulloch A.D. Homogenization modeling for the mechanics of perfused myocardium. Prog. Biophys. Mol. Biol. 1998, 69(2-3):463-481.
54. Lanir Y., Hayam G., Abovsky M., Zlotnick A.Y., Uretzky G., Nevo E., et al. Effect of myocardial swelling on residual strain in the left ventricle of the rat. Am. J. Physiol. 1996, 270(5 Pt 2):H1736-H1743.
55. Mjaatvedt C.H., Yamamura H., Capehart A.A., Turner D., Markwald R.R. The Cspg2 gene, disrupted in the hdf mutant, is required for right cardiac chamber and endocardial cushion formation. Dev. Biol. 1998, 202(1):56-66.
56. Watanabe H., Kimata K., Line S., Strong D., Gao L.Y., Kozak C.A., et al. Mouse cartilage matrix deficiency (cmd) caused by a 7 bp deletion in the aggrecan gene. Nat. Genet. 1994, 7(2):154-157.
57. Costell M., Carmona R., Gustafsson E., Gonzalez-Iriarte M., Fassler R., Munoz-Chapuli R. Hyperplastic conotruncal endocardial cushions and transposition of great arteries in perlecan-null mice. Circ. Res. 2002, 91(2):158-164.
58. Danielson K.G., Baribault H., Holmes D.F., Graham H., Kadler K.E., Iozzo R.V. Targeted disruption of decorin leads to abnormal collagen fibril morphology and skin fragility. J. Cell. Biol. 1997, 136(3):729-743.
59. Xu T., Bianco P., Fisher L.W., Longenecker G., Smith E., Goldstein S., et al. Targeted disruption of the biglycan gene leads to an osteoporosis-like phenotype in mice. Nat. Genet. 1998, 20(1):78-82.
60. Weis S.M., Zimmerman S.D., Shah M., Covell J.W., Omens J.H., Ross J., et al. A role for decorin in the remodeling of myocardial infarction. Matrix. Biol. 2005, 24(4):313-324.
61. Campbell P.H., Hunt D.L., Jones Y., Harwood F., Amiel D., Omens J.H., et al. Effects of biglycan deficiency on myocardial infarct structure and mechanics. Mol. Cell. Biomech. 2008, 5(1):27-35.
62. Westermann D., Mersmann J., Melchior A., Freudenberger T., Petrik C., Schaefer L., et al. Biglycan is required for adaptive remodeling after myocardial infarction. Circulation 2008, 117(10):1269-1276.
63. Braunlin E.A., Berry J.M., Whitley C.B. Cardiac findings after enzyme replacement therapy for mucopolysaccharidosis type I. Am. J. Cardiol. 2006, 98(3):416-418.